drugset / Trial / NCT00043368
PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This protocol allows patients who completed Coley oncology studies using PF-3512676 (CPG 7909) Injection to continue receiving the treatment until disease progression.
Timeline
- Start
- 2002-09
- Primary completion
- 2007-06
- Completion
- 2007-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | agatolimod | Oligonucleotide (other) | 0.01 mg/kg | Intravenous |
| Subject | agatolimod | Oligonucleotide (other) | 0.04 mg/kg | Intravenous |
| Subject | agatolimod | Oligonucleotide (other) | 0.16 mg/kg | Intravenous |
| Subject | agatolimod | Oligonucleotide (other) | 0.2 mg/kg | Intravenous |
| Subject | agatolimod | Oligonucleotide (other) | 0.28 mg/kg | Intravenous |
| Subject | agatolimod | Oligonucleotide (other) | 0.32 mg/kg | Intravenous |
| Subject | agatolimod | Oligonucleotide (other) | 6 mg | Intravenous |
| Subject | agatolimod | Oligonucleotide (other) | 10 mg | Intravenous |
| Subject | agatolimod | Oligonucleotide (other) | 40 mg | Intravenous |